Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib

BACKGROUND AND AIMS: Sorafenib is the standard of care for patients with advanced hepatocellular carcinoma (HCC), yet treatment safety may be challenged by portal hypertension. We therefore assessed the prevalence, risk factors and clinical consequences of esophageal varices (EVs) in sorafenib-treat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:United European Gastroenterol J
Autors principals: Iavarone, Massimo, Primignani, Massimo, Vavassori, Sara, Sangiovanni, Angelo, La Mura, Vincenzo, Romeo, Raffaella, Colombo, Massimo
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2015
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924436/
https://ncbi.nlm.nih.gov/pubmed/27403302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640615615041
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars